Literature DB >> 15374942

A novel role for the coxsackie adenovirus receptor in mediating tumor formation by lung cancer cells.

Min Qin1, Brian Escuadro, Mariam Dohadwala, Sherven Sharma, Raj K Batra.   

Abstract

The Coxsackie Adenovirus Receptor (CAR) has primarily been studied in its role as the initial cell surface attachment receptor for Coxsackie and group C adenoviruses. Recent reports suggest that CAR mediates homotypic intercellular adhesion as part of the tight and/or adherens junction. Thus, CAR is well positioned to participate in intercellular interactions and signaling. Using an antisense (AS)-CAR plasmid vector, we silenced surface CAR expression in lung cancer cells that possessed a high basal expression of this molecule and monitored the resultant tumorigenesis. AS-CAR transfectants exhibit a profound loss in the ability to generate xenografts in scid/scid mice. The emergence of delayed-onset tumors in animals that received injection with AS-CAR transfectants correlates with the resurfacing of CAR expression, suggesting that such expression and tumor emergence are temporally related. To study the mechanism underlying the differences in tumorigenicity, control and AS-CAR cells were compared in terms of their in vitro growth potential. Whereas only subtle differences in the proliferative capacity of the two populations were evident when assayed with growth on plastic, significant differences became apparent when one compared the relative ability of these populations to form colonies in soft agar. These data indicate that silencing surface CAR expression abrogates xenograft tumorigenesis in vivo and colony formation in vitro and invoke the novel possibility that CAR expression is needed for the efficient formation of tumors by a subset of lung cancer cells.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15374942     DOI: 10.1158/0008-5472.CAN-04-1490

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  11 in total

1.  Regulation of the blood-testis barrier by coxsackievirus and adenovirus receptor.

Authors:  Linlin Su; Dolores D Mruk; C Yan Cheng
Journal:  Am J Physiol Cell Physiol       Date:  2012-08-08       Impact factor: 4.249

2.  Coxsackie-adenovirus receptor as a novel marker of stem cells in treatment-resistant non-small cell lung cancer.

Authors:  Xiaochun Zhang; Bingliang Fang; Radhe Mohan; Joe Y Chang
Journal:  Radiother Oncol       Date:  2012-09-27       Impact factor: 6.280

3.  Coxsackievirus and adenovirus receptor expression in non-malignant lung tissues and clinical lung cancers.

Authors:  Yong Wang; Shizhong Wang; Yongyi Bao; Cheng Ni; Naifu Guan; Jianzhong Zhao; Leif G Salford; Bengt Widegren; Xiaolong Fan
Journal:  J Mol Histol       Date:  2006-09-22       Impact factor: 2.611

4.  A heparan sulfate-targeted conditionally replicative adenovirus, Ad5.pk7-Delta24, for the treatment of advanced breast cancer.

Authors:  T Ranki; A Kanerva; A Ristimäki; T Hakkarainen; M Särkioja; L Kangasniemi; M Raki; P Laakkonen; S Goodison; A Hemminki
Journal:  Gene Ther       Date:  2006-08-10       Impact factor: 5.250

5.  Profiling Subcellular Protein Phosphatase Responses to Coxsackievirus B3 Infection of Cardiomyocytes.

Authors:  Millie Shah; Christian M Smolko; Sarah Kinicki; Zachary D Chapman; David L Brautigan; Kevin A Janes
Journal:  Mol Cell Proteomics       Date:  2017-02-07       Impact factor: 5.911

6.  Treatment of radioresistant stem-like esophageal cancer cells by an apoptotic gene-armed, telomerase-specific oncolytic adenovirus.

Authors:  Xiaochun Zhang; Ritsuko Komaki; Li Wang; Bingliang Fang; Joe Y Chang
Journal:  Clin Cancer Res       Date:  2008-05-01       Impact factor: 12.531

7.  Expression of the coxsackie and adenovirus receptor in human lung cancers.

Authors:  Zhaoli Chen; Qian Wang; Jingran Sun; Ankang Gu; Min Jin; Zhiqiang Shen; Zhigang Qiu; Jingfeng Wang; Xinwei Wang; Zhongli Zhan; Jun-Wen Li
Journal:  Tumour Biol       Date:  2013-01-11

8.  Impact of the coxsackievirus and adenovirus receptor on the adenoma-carcinoma sequence of colon cancer.

Authors:  K Stecker; M Vieth; A Koschel; B Wiedenmann; C Röcken; M Anders
Journal:  Br J Cancer       Date:  2011-04-05       Impact factor: 7.640

9.  KIF22 coordinates CAR and EGFR dynamics to promote cancer cell proliferation.

Authors:  Rosemary Pike; Elena Ortiz-Zapater; Brooke Lumicisi; George Santis; Maddy Parsons
Journal:  Sci Signal       Date:  2018-01-30       Impact factor: 8.192

10.  CAR regulates epithelial cell junction stability through control of E-cadherin trafficking.

Authors:  Penny E Morton; Alexander Hicks; Theodoros Nastos; George Santis; Maddy Parsons
Journal:  Sci Rep       Date:  2013-10-07       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.